Company profile
Ticker
AVNR
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Avanir Pharmaceuticals, Lidak Pharmaceuticals
SEC CIK
Corporate docs
IRS number
330314804
Latest filings (excl ownership)
ARS
2014 FY
Annual report to shareholders
28 Apr 15
15-12B
Securities registration termination
15 Jan 15
EFFECT
Notice of effectiveness
14 Jan 15
EFFECT
Notice of effectiveness
14 Jan 15
25-NSE
Exchange delisting
13 Jan 15
8-K
Completion of Acquisition or Disposition of Assets
13 Jan 15
POS AM
Prospectus update (post-effective amendment)
13 Jan 15
POS AM
Prospectus update (post-effective amendment)
13 Jan 15
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jan 15
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jan 15
Latest ownership filings
SC 13G/A
Avanir Pharmaceuticals, Inc.
11 Feb 15
SC 13G/A
Avanir Pharmaceuticals, Inc.
10 Feb 15
SC 13G/A
Avanir Pharmaceuticals, Inc.
9 Feb 15
SC 13G/A
Avanir Pharmaceuticals, Inc.
26 Jan 15
SC 13G/A
Avanir Pharmaceuticals, Inc.
12 Jan 15
SC 13G/A
Beneficial ownership report (amended)
10 Nov 14
SC 13G/A
Avanir Pharmaceuticals, Inc.
10 Nov 14
SC 13G/A
Avanir Pharmaceuticals, Inc.
12 Sep 14
SC 13G
Avanir Pharmaceuticals, Inc.
10 Jun 14
SC 13G/A
Avanir Pharmaceuticals, Inc.
14 Feb 14
Institutional ownership, Q4 2020
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
IFP Advisors | 0.00 | $0.00 |